Literature DB >> 17502234

Clinical care of the HIV-infected drug user.

R Douglas Bruce1, Frederick L Altice.   

Abstract

HIV/AIDS and chemical dependency, the latter often intertwined with mental illness, are complex, overlapping spheres that adversely influence each other and the overall clinical outcomes of the affected individual. Each disorder individually impact tens of millions of people adversely, with explosive epidemics described worldwide. This article addresses the adverse consequences of HIV/AIDS, drug injection, the secondary comorbidities of both, and the impact of immunosuppression on presentation of disease as well as approaches to managing the HIV-infected drug user.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502234      PMCID: PMC2128697          DOI: 10.1016/j.idc.2007.03.009

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  121 in total

Review 1.  The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe.

Authors:  Jeffrey A Kelly; Yuri A Amirkhanian
Journal:  Int J STD AIDS       Date:  2003-06       Impact factor: 1.359

Review 2.  Clinical practice. Office-based treatment of opioid-dependent patients.

Authors:  David A Fiellin; Patrick G O'Connor
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

3.  Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study.

Authors:  Charles A Dackis; Kevin G Lynch; Elmer Yu; Frederick F Samaha; Kyle M Kampman; James W Cornish; Amy Rowan; Sabrina Poole; Lenae White; Charles P O'Brien
Journal:  Drug Alcohol Depend       Date:  2003-05-01       Impact factor: 4.492

4.  Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men.

Authors:  Thomas Perdue; Holly Hagan; Hanne Thiede; Linda Valleroy
Journal:  AIDS Educ Prev       Date:  2003-02

5.  Patterns of drug use and risk-taking among injecting amphetamine and opioid drug users in Sydney, Australia.

Authors:  W Hall; S Darke; M Ross; A Wodak
Journal:  Addiction       Date:  1993-04       Impact factor: 6.526

6.  High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.

Authors:  Eric C Donny; Sharon L Walsh; George E Bigelow; Thomas Eissenberg; Maxine L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  2002-03-13       Impact factor: 4.530

7.  The impact of needle exchange-based health services on emergency department use.

Authors:  Harold A Pollack; Kaveh Khoshnood; Kim M Blankenship; Frederick L Altice
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

8.  HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy.

Authors:  S C Kalichman; D Rompa
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

Review 9.  Naltrexone maintenance treatment for opioid dependence.

Authors:  U Kirchmayer; M Davoli; A Verster
Journal:  Cochrane Database Syst Rev       Date:  2002

Review 10.  Liver disease in alcohol and hepatitis C.

Authors:  M Mazen Jamal; Timothy R Morgan
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-08       Impact factor: 3.043

View more
  40 in total

Review 1.  Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Authors:  Pria Anand; Sandra A Springer; Michael M Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2010-12

2.  Psychosocial factors in adherence to antiretroviral therapy among HIV-positive people who use drugs.

Authors:  William K Lee; M J S Milloy; John Walsh; Paul Nguyen; Evan Wood; Thomas Kerr
Journal:  Health Psychol       Date:  2015-12-21       Impact factor: 4.267

3.  Enhanced HIV testing, treatment, and support for HIV-infected substance users.

Authors:  Nora D Volkow; Julio Montaner
Journal:  JAMA       Date:  2010-04-14       Impact factor: 56.272

4.  Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia.

Authors:  Muhammad Muhsin Zahari; Woong Hwan Bae; Nor Zuraida Zainal; Hussain Habil; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Am J Drug Alcohol Abuse       Date:  2010-01       Impact factor: 3.829

Review 5.  Challenges in managing HIV in people who use drugs.

Authors:  Adeeba Kamarulzaman; Frederick L Altice
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

6.  HIV Patients' Preference for Integrated Models of Addiction and HIV Treatment in Vietnam.

Authors:  Diep Nguyen Bich; P Todd Korthuis; Trang Nguyen Thu; Hoa Van Dinh; Giang Le Minh
Journal:  J Subst Abuse Treat       Date:  2016-07-19

7.  Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market.

Authors:  R Douglas Bruce; Sumathi Govindasamy; Laurie Sylla; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

8.  Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings.

Authors:  R Douglas Bruce
Journal:  Int J Drug Policy       Date:  2010-03

9.  Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.

Authors:  Cindy Bednasz; Amneris E Luque; Barry S Zingman; Margaret A Fischl; Barbara M Gripshover; Charles S Venuto; Jie Gu; Zekun Feng; Robin DiFrancesco; Gene D Morse; Qing Ma
Journal:  Curr Vasc Pharmacol       Date:  2016       Impact factor: 2.719

10.  Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment.

Authors:  Brandon Aden; Allison Dunning; Bohdan Nosyk; Eve Wittenberg; Jeremy W Bray; Bruce R Schackman
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.